Externally Validated Machine Learning Models for 30-/90-/180-Day Unplanned Readmission After Head and Neck Cancer Hospitalizations in the United States Between January and June 2025, diagnostic ...

The prevalence of objectively measurable disease in phase III trials of metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers ...

A team of researchers from Google Health, working with others from institutions across the U.S. and Canada has found that a Google AI system was able to outperform general pathologists when validating ...

Former U.S. President Joe Biden’s recent cancer diagnosis brought widespread attention to what is known as the “Gleason score,” a grading system used to assess the prognosis of men with prostate ...